Sales & Marketing

Enter the Maturity Matrix: the future of KOL management organization.

In an effort to give healthcare professionals and patients a one-stop source for factual drug safety information and treatment options, Pfizer has launched a handy new medicine safety Web site with a bevy of bells and whistles.

A new FDA Web site defines consumer print advertising so the general public can spot bad and good pharma ads. As a bonus, the site also serves as a checklist for pharma marketers trying not to step on any regulatory toes.

A new study finds that doctors are three times more likely to prescribe generics when they don’t have access to free samples of branded drugs.

Celebrity spokesperson Dr. Jarvik has been replaced with a Regular Joe in the latest Lipitor DTC spots. Will the switch make a difference?

The smart way to CRM is through SaaS

A new study tracks six high-traffic drugs that are turning up on shady online pharmacies, usually at huge discounts. The conclusion: Fancy Web sites are suckering customers and costing pharma money and credibility.

Do consumers pay attention to risk information in television ads? FDA plans to find out with a study using phony ads for a nonexistent blood pressure drug.

Crohn?s disease is the topic of conversation on the first Abbott unbranded podcast. The company talks about why it went the radio route.

How a diabetes field team helped docs overcome the treatment gap

The new Phrma marketing code bans pens and pads and other non-educational gifts. It bans dinners with docs (but not the lunch-and-learn). And it requires compliance. Are we safer yet?

With the launch of the Center for Communication Compliance, pharma companies and PR firms have a one-stop resource to educate themselves about marketing regulations in an effort to reduce accidental non-compliance.

An innovative approach bridges the pediatric communication gap

A strict marketing regimen will help keep your brand healthy in the digital

On Monday, a handful of Big Pharma companies told Congress that they would put a six-month moratorium on drug ads for recently approved medication. Pfizer, Merck, Schering-Plough, and Johnson & Johnson also agreed to closely follow the American Medical Association's guidelines when using actors playing physicians in advertisements.

Do you really know who you are hiring? Agency Insider Mark Chataway spills the beans on why the pitch doesn't work, and what you need to do before signing on

At a time when current sales and marketing models are unsustainable, pharma is still slow to adopt online opportunities

When it comes to marketing, every syllable speaks volumes

Pharma is taking note of online video's power to affect B2B communications

American Red Cross scores a win against Johnson & Johnson in a legal battle over the use of one of the healthcare?s most recognizable symbols

FDA takes the opportunity to remind industry what reminder ads are, as promotional material for Shire's Fosrenol is deemed in violation of advertising rules

Marketers and sales reps feel the brunt of faltering Procrit sales as J&J consolidates its biologics divisions.

Consumer advertising might be taking a hit in the media and Congress, but pharma was all smiles at this year's PhAME Awards as the best DTC campaigns took the spotlight

Technology isn't the magic bullet, but it can help you hit your target

The tech-savvy creative team at Concentric Rx has its sales force mixing work and play

Thanks to Dr. Google and Nurse Yahoo, pharma consumers know better than ever how to get exactly what they want

Promotional spending is down as companies rationalize and optimize budgets. But in contrast to big changes on the sales side, marketers are still trying to make the old model work

As companies make headway with Web promotions, their marketers express concerns about how best to benchmark online efforts.

Blog entries about branded drugs-both positive and negative-are turning up in online keyword searches. Should pharma be worried?

GSK, Pfizer, and Merck have jumped on the cell-phone marketing bandwagon, but most of pharma is still tiptoeing around the technology. A new report details how pharma can get consumers to text for health info.